MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/pcn5.70228

Медицинская библиотека · PCN reports : psychiatry and clinical neurosciences · 2025

Association between higher cerebrospinal fluid levels of phosphorylated tau and reduced depressive symptoms in patients with cognitive decline.

Ozaki Takashi, Hashimoto Naoki, Narita Hisashi, Udo Niki, Mito Shizuka, Nakagawa Shin, Kusumi Ichiro, Kato Takahiro A

СтатьяПеревод в очереди

Аннотация

AIM: In individuals with cognitive decline, depressive symptoms can affect disease progression and quality of life. One factor that may be associated with depressive symptoms is phosphorylated tau (p-tau). However, the association between p-tau and depressive symptoms remains controversial. The present study examined the relationship between p-tau levels and depressive symptoms not only in terms of total scale scores of the 15-item Geriatric Depression Scale (GDS-15) but also at the item level.

METHODS

We conducted a cross-sectional survey of patients (n = 88) with mild cognitive impairment due to Alzheimer's disease (AD) or with AD dementia (ADD), who were strictly diagnosed by a board of psychiatrists and neurologists from Hokkaido University Hospital. All patients underwent lumbar puncture to obtain cerebrospinal fluid for the p-tau assessment. We first investigated the association between p-tau level and GDS-15 total score. Next, we compared the p-tau levels for each item using the GDS-15 with binary responses "none (0)" or "present (1)."

RESULTS

Multivariable regression analysis revealed that higher levels of p-tau were significantly associated with lower GDS-15 total scores (standardized coefficient [95% confidence interval] = -0.28, [-0.48, -0.09]). Furthermore, patients with higher p-tau levels were less likely to have symptoms of GDS-15 Items 2 (Dropped interests) (p < 0.001) and 14 (Hopeless) (p = 0.0030).

CONCLUSION

Our findings suggest an association between p-tau accumulation and reduced depressive symptoms. However, future longitudinal studies are required to confirm whether p-tau may be a predictive factor for depressive symptoms.

Для цитирования: Ozaki Takashi, Hashimoto Naoki, Narita Hisashi, Udo Niki, Mito Shizuka, Nakagawa Shin, Kusumi Ichiro, Kato Takahiro A. Association between higher cerebrospinal fluid levels of phosphorylated tau and reduced depressive symptoms in patients with cognitive decline.. PCN reports : psychiatry and clinical neurosciences. 2025. DOI: 10.1002/pcn5.70228.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.